Lucie Heinzerling

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Top Venues

Cancer immunology, immunotherapy : CII

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Theresa Ruf, Anna Leonhardt, David Anz, Wolfgang G Kunz, Natascha Röhrle, Paul Foerster, Dirk Tomsitz, Lars Einar French, Marlene Seegräber, Lucie Heinzerling
Tumor lysis syndrome induced by tebentafusp. Immunotherapy (2023)
Leonie Müller-Jensen, Axel Ronald Schulz, Henrik E Mei, Raphael Mohr, Claas Ulrich, Philipp Knape, Nikolaj Frost, Stefan Frischbutter, Désirée Kunkel, Christian Schinke, Lorena Ginesta Roque, Smilla K Maierhof, Florian T Nickel, Lucie Heinzerling, Matthias Endres, Wolfgang Boehmerle, Petra Huehnchen, Samuel Knauss
Immune signatures of checkpoint inhibitor-induced autoimmunity - a focus on neurotoxicity. Neuro-oncology (2023)
Sarah Zierold, Larissa Semra Akcetin, Eva Gresser, Anna Marie Maier, Alexander König, Rafaela Kramer, Sebastian Theurich, Dirk Tomsitz, Michael Erdmann, Lars E French, Martina Rudelius, Lucie Heinzerling
Checkpoint-inhibitor induced Polyserositis with Edema. Cancer immunology, immunotherapy : CII 71 (12) (2022)
Alvaro Moreira, Lucie Heinzerling, Nina Bhardwaj, Philip Friedlander
Current Melanoma Treatments: Where Do We Stand? Cancers 13 (2) (2021)
Stefanie Hoyer, Valentina Eberlein, Gerold Schuler, Carola Berking, Lucie Heinzerling, Niels Schaft, Jan Dörrie
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation. International journal of molecular sciences 22 (21) (2021)